GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haleon PLC (XTER:H6D0) » Definitions » Long-Term Capital Lease Obligation

Haleon (XTER:H6D0) Long-Term Capital Lease Obligation : €0 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Haleon Long-Term Capital Lease Obligation?

Haleon's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was €0 Mil.

Haleon's quarterly Long-Term Capital Lease Obligation increased from Sep. 2023 (€0 Mil) to Dec. 2023 (€103 Mil) but then declined from Dec. 2023 (€103 Mil) to Mar. 2024 (€0 Mil).

Haleon's annual Long-Term Capital Lease Obligation increased from Dec. 2021 (€102 Mil) to Dec. 2022 (€135 Mil) but then declined from Dec. 2022 (€135 Mil) to Dec. 2023 (€103 Mil).


Haleon Long-Term Capital Lease Obligation Historical Data

The historical data trend for Haleon's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haleon Long-Term Capital Lease Obligation Chart

Haleon Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Capital Lease Obligation
142.73 116.01 102.39 134.53 103.31

Haleon Quarterly Data
Dec19 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Long-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 122.37 - 103.31 -

Haleon  (XTER:H6D0) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Haleon Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Haleon's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Haleon (XTER:H6D0) Business Description

Industry
Traded in Other Exchanges
Address
The Heights, Building 5, First Floor, Surrey, Weybridge, GBR, KT13 0NY
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Haleon (XTER:H6D0) Headlines

No Headlines